{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:55Z","timestamp":1759336555741,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.arteri.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:36:06Z","timestamp":1560792966000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fenotipo de la haptoglobina y presencia de enfermedad vascular subcl\u00ednica: estudio poblacional"],"prefix":"10.1016","volume":"32","author":[{"given":"Jose M.","family":"Mostaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaya","family":"de Dios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"P\u00e9rez Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Salinero-Fort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Estirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Garc\u00eda-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Gonz\u00e1lez Alegre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concesa","family":"Sab\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2019.03.007_bib0130","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/2047487318776829","article-title":"The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus","volume":"25","author":"Dalan","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2011.01.029","article-title":"Haptoglobin genotype and the iron hypothesis of atherosclerosis","volume":"216","author":"Viener","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2019.03.007_bib0140","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/db08-0450","article-title":"Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype","volume":"57","author":"Asleh","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.arteri.2019.03.007_bib0145","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1074\/jbc.M411390200","article-title":"Assignment of the binding site for haptoglobin on apolipoprotein A-I","volume":"280","author":"Spagnuolo","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arteri.2019.03.007_bib0150","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.arteri.2019.03.007_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/vhrm.1.1.19.58930","article-title":"In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease","volume":"1","author":"Asleh","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.arteri.2019.03.007_bib0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1479164116645247","article-title":"The haptoglobin 2-2 genotype is associated with inflammation and carotid artery intima-media thickness","volume":"13","author":"Dalan","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.arteri.2019.03.007_bib0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cca.2009.12.025","article-title":"The haptoglobin 2-2 genotype is associated with carotid atherosclerosis in 64-year old women with established diabetes","volume":"411","author":"Ryndel","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arteri.2019.03.007_bib0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2840-12-31","article-title":"Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type2 diabetes in the Diabetes Heart Study","volume":"12","author":"Adams","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0175","first-page":"49","article-title":"Factores de riesgo asociados con el grosor \u00edntima-media y la presencia de placas en arteria car\u00f3tida: Estudio ESPREDIA","volume":"30","author":"Mostaza","year":"2018","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2019.03.007_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2019.03.007_bib0185","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1515\/cclm-2013-0018","article-title":"An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype","volume":"51","author":"Levy","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.arteri.2019.03.007_bib0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004-2006): An update on behalf of the advisory board of the 3rd and 4th Watching the Risk Symposium 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2019.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2015.07.076","article-title":"The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the haptoglobin 2-2 genotype","volume":"66","author":"Cahill","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacc.2012.09.063","article-title":"Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin","volume":"61","author":"Cahill","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0205","doi-asserted-by":"crossref","first-page":"e000732","DOI":"10.1161\/JAHA.113.000732","article-title":"Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin \u2014 results from the Bruneck Study","volume":"3","author":"Pechlaner","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.arteri.2019.03.007_bib0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2003.10.014","article-title":"Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort","volume":"172","author":"Levy","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2019.03.007_bib0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng.3510","article-title":"Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels","volume":"48","author":"Boettger","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.arteri.2019.03.007_bib0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/jhg.2017.66","article-title":"A common deletion in the haptoglobin gene associated with blood cholesterol levels among Chinese women","volume":"62","author":"Zheng","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.arteri.2019.03.007_bib0225","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1111\/j.1742-4658.2009.07319.x","article-title":"Haptoglobin binds the antiatherogenic protein apolipoproteinE \u2014 impairment of apolipoproteinE stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes","volume":"276","author":"Cigliano","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.arteri.2019.03.007_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1471-4159.2009.06121.x","article-title":"Haptoglobin binds apolipoproteinE and influences cholesterol esterification in the cerebrospinal fluid","volume":"110","author":"Salvatore","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.arteri.2019.03.007_bib0235","doi-asserted-by":"crossref","first-page":"e57571","DOI":"10.1371\/journal.pone.0057571","article-title":"VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arteri.2019.03.007_bib0240","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000327822","article-title":"Haptoglobin polymorphism as a risk factor for chronic kidney disease: A case-control study","volume":"33","author":"Chen","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/S0066-782X2011005000107","article-title":"Haptoglobin genotypes and refractory hypertension in type2 diabetes mellitus patients","volume":"97","author":"Wobeto","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.arteri.2019.03.007_bib0250","first-page":"71","article-title":"Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitaminE supplementation","volume":"11","author":"Asleh","year":"2018","journal-title":"Pharmgenomics Pers Med"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:31:27Z","timestamp":1759325487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916819300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0214916819300506"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2019.03.007","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenotipo de la haptoglobina y presencia de enfermedad vascular subcl\u00ednica: estudio poblacional","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}